Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
出版年份 2020 全文链接
标题
Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-18
DOI
10.1038/s41598-020-59736-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
- (2019) Johann S de Bono et al. LANCET ONCOLOGY
- Icon immunoconjugate treatment results in regression of red lesions in a non-human primate ( Papio anubis ) model of endometriosis
- (2018) Demetra Hufnagel et al. Reproductive Biology
- Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON
- (2018) Zhiwei Hu et al. Cancer Immunology Research
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Treating Tissue Factor-Positive Cancers With Antibody-Drug Conjugates That Do Not Affect Blood Clotting
- (2018) Jan-Willem Theunissen et al. MOLECULAR CANCER THERAPEUTICS
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- The Tissue Factor Pathway and Wound Healing
- (2017) Maureane Hoffman SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy
- (2016) Zhiwei Hu et al. ANGIOGENESIS
- Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
- (2016) Paulina J. Paszkiewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer
- (2016) Zhiwei Hu et al. Oncotarget
- Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG mice
- (2016) Qing Zhang et al. Oncotarget
- Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8
- (2015) Qi Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
- (2015) E. Verronèse et al. OncoImmunology
- Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin
- (2014) Gabriela Cesarman-Maus et al. THROMBOSIS RESEARCH
- Molecularly targeted therapies for metastatic triple-negative breast cancer
- (2013) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer
- (2011) Cornelia Liedtke et al. Breast Care
- Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy
- (2011) J Duanmu et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metastatic Triple-negative Breast Cancer
- (2011) E.A. Rakha et al. CLINICAL ONCOLOGY
- Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
- (2011) J. Cheng et al. CURRENT CANCER DRUG TARGETS
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
- (2011) Abderrahim El Guerrab et al. PLoS One
- Regulation of NK92-MI Cell Cytotoxicity by Substance P
- (2011) W. X. Fu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
- (2010) N. Berrada et al. ANNALS OF ONCOLOGY
- Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivoin mice
- (2010) Zhiwei Hu et al. BMC CANCER
- Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer
- (2010) Zhiwei Hu et al. BMC IMMUNOLOGY
- Tissue factor in cancer progression and angiogenesis
- (2010) Wolfram Ruf et al. THROMBOSIS RESEARCH
- The Immunoconjugate “Icon” Targets Aberrantly Expressed Endothelial Tissue Factor Causing Regression of Endometriosis
- (2009) Graciela Krikun et al. AMERICAN JOURNAL OF PATHOLOGY
- Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
- (2009) Farrah Kassam et al. Clinical Breast Cancer
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation